河北美邦工程科技股份有限公司 证券代码：832471 证券简称：美邦科技 公告编号：2024-038 2023 年度独立董事述职报告（林金锋） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为河北美邦工程科技股份有限公司（以下简称"公司"）的独立董事， 2023 年度本人严格按照《中华人民共和国公司法》《北京证券交易所股票上市 规则（试行）》《北京证券交易所上市公司持续监管指引第 1 号——独立董事》 等有关法律、法规及《公司章程》《独立董事工作制度》的相关规定和要求，诚 实、勤勉、独立地履行职务，积极出席相关会议，认真审议董事会各项议案， 并针对相关议案发表独立性意见，切实维护了公司和全体股东尤其是中小股东 的合法权益。 现将 2023 年度本人履行独立董事职责情况汇报如下： 一、独立董事独立性情况 作为公司的独立董事，本人及本人直系亲属均不在公司或其附属企业担任 除独立董事之外的其他职务，也未在公司主要股东处担任任何职务；没有为公 司或其附属企业提供财务、法律、咨询等服务。除独立董事津贴外，没有 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-048 河北美邦工程科技股份有限公司 关于召开 2023 年年度股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开基本情况 （一）股东大会届次 本次会议为 2023 年年度股东大会。 （二）召集人 本次股东大会的召集人为董事会。 召开本次会议的议案已于 2024 年 4 月 23 日经公司第四届董事会第二次 会议审议通过。 （三）会议召开的合法性、合规性 本次股东大会的召开、召集符合相关法律法规、规范性文件及《公司法》 《公司章程》的规定。本次会议召开不存在尚需相关部门批准的情形。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司同一股东只能选择现场投票、网络投票中的一种方式，同一表决权 出现重复表决的，以第一次投票结果为准。 （五）会议召开日期和时间 1、现场会议召开时间：2024 年 5 月 15 日 14：00。 2、网络投票起止时间：2024 年 5 月 14 日 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-037 2023 年度独立董事述职报告（冯文英） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为河北美邦工程科技股份有限公司（以下简称"公司"）的独立董事， 2023 年度本人严格按照《中华人民共和国公司法》《北京证券交易所股票上市 规则（试行）》《北京证券交易所上市公司持续监管指引第 1 号——独立董事》 等有关法律、法规及《公司章程》《独立董事工作制度》的相关规定和要求，诚 实、勤勉、独立地履行职务，积极出席相关会议，认真审议董事会各项议案， 并针对相关议案发表独立性意见，切实维护了公司和全体股东尤其是中小股东 的合法权益。 现将 2023 年度本人履行独立董事职责情况汇报如下： 一、独立董事独立性情况 作为公司的独立董事，本人及本人直系亲属均不在公司或其附属企业担任 除独立董事之外的其他职务，也未在公司主要股东处担任任何职务；没有为公 司或其附属企业提供财务、法律、咨询等服务。除独立董事津贴外，没有从公 司及其主要股东或有利害关 ...

河北美邦工程科技股份有限公司 审计报告 大华审字[2024]0011008226 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified PublicAccountants（Special General Partnership） 河北美邦工程科技股份有限公司 审计报告及财务报表 （2023 年 1 月 1 日至 2023 年 12 月 31 日止） | | 目 | 录 | 页 次 | | --- | --- | --- | --- | | 一、 | 审计报告 | | 1-6 | | 二、 | 已审财务报表 | | | | | 合并资产负债表 | | 1-2 | | | 合并利润表 | | 3 | | | 合并现金流量表 | | 4 | | | 合并股东权益变动表 | | 5-6 | | | 母公司资产负债表 | | 7-8 | | | 母公司利润表 | | 9 | | | 母公司现金流量表 | | 10 | | | 母公司股东权益变动表 | | 11-12 | | | 财务报表附注 | | 1-97 | 大华会计师事务所（特殊普通合伙） 北京市海淀区西四环中路 1 ...

| 独立董事 | 应出席董 | 实际出席 | 缺席次数 | 应出席股 | 实际出席 | 缺席次数 | | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 事会次数 | 次数 | | 东会次数 | 次数 | | | 沈晓冬 | 9 | 9 | 0 | 7 | 7 | 0 | 证券代码：832471 证券简称：美邦科技 公告编号：2024-036 河北美邦工程科技股份有限公司 2023 年度独立董事述职报告（沈晓冬） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为河北美邦工程科技股份有限公司（以下简称"公司"）的独立董事， 2023 年度本人严格按照《中华人民共和国公司法》《北京证券交易所股票上市 规则（试行）》《北京证券交易所上市公司持续监管指引第 1 号——独立董事》 等有关法律、法规及《公司章程》《独立董事工作制度》的相关规定和要求，诚 实、勤勉、独立地履行职务，积极出席相关会议，认真审议董事会各项议案， 并针对相关议案发表独立性意见，切实维护了 ...

Corporate Governance and Structure - The company has established a unified action agreement among its actual controllers to maintain consistent voting behavior in board and shareholder meetings[129]. - The board of directors consists of 7 members, while the supervisory board has 3 members, and there are 7 senior management personnel[145]. - The company has established a clear and transparent cash dividend policy, ensuring the protection of minority shareholders' rights[142]. - The company has implemented a comprehensive assessment for determining the compensation of directors and senior management based on performance and responsibilities[150]. - The independent directors did not change during the reporting period, maintaining stability in governance[149]. - The company has continuously improved its governance structure and internal control management system in accordance with relevant laws and regulations[197]. - The governance mechanism provides adequate protection and equal rights for all shareholders, particularly minority shareholders[199]. - Major decisions such as amendments to the articles of association and share buybacks were conducted in accordance with established procedures[200]. Financial Performance - The company's operating revenue for 2023 was ¥477,980,447.37, a decrease of 15.32% compared to ¥564,459,985.78 in 2022[31]. - The net profit attributable to shareholders for 2023 was ¥22,569,060.74, down 63.75% from ¥62,252,904.51 in 2022[31]. - The gross profit margin for 2023 was 17.05%, significantly lower than 29.75% in 2022[31]. - Total assets increased by 13.15% to ¥953,964,753.93 at the end of 2023, compared to ¥843,106,834.73 at the end of 2022[33]. - The total liabilities decreased by 7.49% to ¥284,055,763.20 in 2023 from ¥307,037,554.75 in 2022[33]. - The net asset attributable to shareholders rose by 29.80% to ¥557,852,333.45 in 2023, compared to ¥429,763,900.32 in 2022[33]. - The basic earnings per share for 2023 was ¥0.2905, a decline of 67.33% from ¥0.8893 in 2022[31]. - The operating cash flow for 2023 was ¥3,744,942.71, a drastic decrease of 98.04% from ¥191,496,900.62 in 2022[33]. - The company reported a net non-recurring profit of ¥7,941,077.58 for 2023, compared to ¥6,318,642.88 in 2022[40]. - The company achieved a revenue of 477.98 million yuan in 2023, which is a key performance indicator[92]. Research and Development - During the reporting period, the company applied for 13 national patents, including 7 invention patents and 6 utility model patents, and was granted 17 patents, comprising 10 invention patents and 7 utility model patents[11]. - The company is in the industrial trial phase for the HPPO method of propylene oxide production, aiming to optimize catalyst preparation and achieve industry-leading performance[90]. - The company is developing a new type of catalyst for the synthesis of VCM using mercury-free ionic liquids, focusing on enhancing catalyst performance and reducing costs[90]. - The company is conducting research on a sodium sulfate solution purification process to effectively remove water-soluble organic impurities, achieving industrial-grade standards[90]. - The company is in the pilot stage for the production of bio-synthetic pharmaceutical intermediates, enriching its technological reserves in the biological field[91]. - The company is developing low-cost, high-quality enzyme nylon 56 salt production technology, laying the foundation for future industrialization[91]. - R&D expenditure for the period was 21,890,948.27 CNY, accounting for 4.58% of operating revenue, compared to 4.43% in the previous period[87]. - The total number of R&D personnel increased from 55 to 60, with the proportion of R&D staff in total employees rising from 15.71% to 17.44%[88]. - The company has formed partnerships with multiple research institutions to enhance its innovation capabilities and continuously invests in R&D[179]. Market Position and Strategy - The company aims to be a leading manufacturer of fine chemicals and a provider of green technology solutions, focusing on advanced green manufacturing technology[102]. - The company is positioned within a tight industrial chain, contributing to the development of regional industrial clusters such as the "China Spandex Valley" in Ningxia[101]. - The company is committed to innovation and technology development, with a focus on market-oriented product research and development planning[104]. - The company is aware of market fluctuations and plans to adapt its strategies accordingly to mitigate risks associated with market and industry cycles[106]. - The company has established a complete innovation system to enhance its innovation capabilities and mitigate risks associated with new business development[1]. - The company has a focus on green technology innovation and has increased R&D investment in advanced green manufacturing technologies[2]. Environmental and Social Responsibility - The company emphasizes social responsibility by focusing on technological innovation and contributing to clean production and green development in the chemical industry[98]. - The company emphasizes environmental protection and complies with relevant laws and regulations, implementing necessary environmental protection facilities to control pollutants effectively[99]. - The company has achieved compliance with hazardous waste management standards, ensuring proper disposal of waste materials[186]. - The company has established a strict management system for hazardous chemicals, ensuring compliance with relevant laws and regulations throughout the entire process from purchase to disposal[189]. - The company has implemented environmental protection facilities including SCR denitrification devices and wastewater treatment stations to enhance waste treatment capabilities[188]. Shareholder and Capital Management - The company raised ¥141,768,000.00 through the public issuance of 13.2 million shares, resulting in a net fundraising amount of ¥121,525,434.00 after deducting issuance costs[72]. - The company has maintained a consistent strategy in its shareholder structure, with no new significant shareholders introduced during the reporting period[128]. - The company has not faced any major litigation or arbitration matters during the reporting period[4]. - The company has fulfilled all disclosed commitments without any overdue obligations[118]. - The company has not proposed any cash dividend distribution plan despite having positive undistributed profits during the reporting period[144]. - The company has established a training system to enhance employee skills and align them with strategic goals[153]. Operational Performance - The company’s production capacity for toluene oxidation series products increased by 27% year-on-year due to technological upgrades[46]. - The company’s production of benzyl alcohol, a key product, is positioned at the forefront of the industry, utilizing a unique toluene oxidation method[50]. - The company’s THF production process integrates advanced technologies such as reaction distillation and heat coupling, effectively managing pollutants[175]. - The company has achieved industrialization of self-developed technologies in the fields of tetrahydrofuran and toluene oxidation, producing and selling related fine chemicals[188]. - The company has implemented comprehensive safety management measures, including regular safety inspections and training, to ensure a safe production environment[183].

证券代码：832471 证券简称：美邦科技 公告编号：2024-041 河北美邦工程科技股份有限公司 会计师事务所履职情况评估报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 河北美邦工程科技股份有限公司聘请大华会计师事务所（特殊普通合伙） （以下简称"大华"）作为公司 2023 年度审计机构，根据《国有企业、上市公 司选聘会计师事务所管理办法》，公司董事会对大华 2023 年度审计工作的履职 情况进行了评估，具体情况如下: 一、会计师事务所的基本情况 （一）资质条件 会计师事务所名称：大华会计师事务所（特殊普通合伙） 成立日期：2012 年 2 月 9 日 组织形式：特殊普通合伙 注册地址：北京市海淀区西四环中路 16 号 7 号楼 1101 首席合伙人：梁春 2022 年度末合伙人数量：272 人 2022 年收入总额（经审计）：332,731.85 万元 2022 年审计业务收入（经审计）：307,355.10 万元 2022 年证券业务收入（经审计）：138,862.04 万元 2022 年 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-029 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 4 月 23 日 2.会议召开地点：公司会议室 4.发出董事会会议通知的时间和方式：2024 年 4 月 12 日以邮件方式发出 5.会议主持人：董事长高文杲 6.会议列席人员：监事会成员、董事会秘书及公司高级管理人员 河北美邦工程科技股份有限公司 第四届董事会第二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 3.会议召开方式：现场及通讯 1.议案内容： 根据《公司法》和《公司章程》的规定，由公司总经理代表管理层汇报 2023 年度经营工作情况。 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票。 3.回避表决情况： 本议案无需回避表决。 7.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关 法律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席董事 ...

Financial Performance - Operating revenue for Q1 2024 reached CNY 120,656,773.92, a 30.71% increase year-on-year[10] - Net profit attributable to shareholders surged by 210.47% to CNY 2,464,084.47 compared to a loss of CNY 2,230,549.84 in the same period last year[10] - The company's operating profit for Q1 2024 was CNY 6,813,053.27, compared to a loss of CNY 2,891,692.37 in Q1 2023, indicating a turnaround in profitability[37] - Net profit for Q1 2024 was CNY 6,227,468.62, contrasting with a net loss of CNY 1,730,152.92 in Q1 2023, showcasing a substantial improvement in financial performance[37] - Total revenue for Q1 2024 reached CNY 120,656,773.92, a significant increase from CNY 92,305,375.87 in Q1 2023, representing a growth of approximately 30.8%[36] Cash Flow - The net cash flow from operating activities improved by 189.33% to CNY 12,800,528.85, compared to a negative cash flow of CNY 14,329,491.78 in Q1 2023[12] - The company reported cash inflows from investment activities of ¥10,178,018.58 million in Q1 2024, a decrease from ¥49,918,493.31 million in Q1 2023[43] - The net cash flow from financing activities was -¥872,597.52 million in Q1 2024, compared to -¥4,817,988.25 million in Q1 2023, indicating a reduction in financing losses[43] - Net cash flow from operating activities for Q1 2024 was $16,301,051.07, compared to a negative cash flow of -$5,229,998.71 in Q1 2023, indicating a strong turnaround[46] Assets and Liabilities - Total assets increased by 2.55% to CNY 978,257,548.79 compared to the end of last year[10] - The company's asset-liability ratio increased to 31.39% from 29.78% at the end of the previous year[10] - The total liabilities increased to ¥307,076,410.24 from ¥284,055,763.20, reflecting a rise of about 8.1%[32] - The total value of assets under restriction due to bank loans is CNY 162,255,326.18, which accounts for 16.58% of total assets[27] Shareholder Information - The total number of shares held by the top ten shareholders is 55,975,532, representing 67.27% of the total shares[18] - The largest shareholder, Gao Wengao, holds 23,022,000 shares, accounting for 27.67% of the total shares[17] - The company plans to repurchase shares at a price not exceeding CNY 12.80 per share, with a total repurchase fund of no less than CNY 10,000,000 and no more than CNY 20,000,000[24] Research and Development - Research and development expenses for Q1 2024 were CNY 4,618,555.66, slightly down from CNY 4,472,336.55 in Q1 2023, suggesting stable investment in innovation[36] - Research and development expenses increased to ¥648,439.09 million in Q1 2024 from ¥565,117.66 million in Q1 2023, showing a commitment to innovation[40] Other Financial Metrics - The weighted average return on equity based on net profit attributable to shareholders was 0.44%, up from -0.52% in the same period last year[10] - Basic and diluted earnings per share for Q1 2024 were both CNY 0.0296, a recovery from a loss of CNY 0.0319 in Q1 2023[38] - The company experienced a credit impairment loss of CNY -1,128,501.04 in Q1 2024, worsening from CNY -1,808,459.05 in Q1 2023, highlighting ongoing challenges in credit quality[37] Inventory and Receivables - The company reported a significant increase in accounts receivable financing, up 98.39% to CNY 32,864,205.75 due to an increase in notes receivable[11] - Inventory shares increased by 772.35% to CNY 7,058,490.48 as the company repurchased shares[11] - Accounts receivable slightly decreased to ¥38,507,032.89 from ¥39,093,526.06, a reduction of approximately 1.5%[30] Commitments and Legal Matters - The company has no new commitments as of the reporting period, and all previously disclosed commitments are being fulfilled normally[25] - The company has no litigation or arbitration matters during the reporting period[21] - The company has no shareholder or related party fund occupation or transfer issues[21] - The company has no new pledges or judicial freezes on shares held by shareholders[19]

证券代码：832471 证券简称：美邦科技 公告编号：2024-030 河北美邦工程科技股份有限公司 第四届监事会第二次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 5.会议主持人：监事会主席马记 6.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于 2023 年度监事会工作报告的议案》 1.议案内容： 根据《公司法》和《公司章程》的规定，由公司监事会主席代表监事会汇 报 2023 年度监事会工作情况。 2.议案表决结果：同意 3 票；反对 0 票；弃权 0 票。 1.会议召开时间：2024 年 4 月 23 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出监事会会议通知的时间和方式：2024 年 4 月 ...